IC

Ikarian Capital Portfolio holdings

AUM $302M
This Quarter Return
+37.65%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$241M
AUM Growth
+$241M
Cap. Flow
-$3.2M
Cap. Flow %
-1.33%
Top 10 Hldgs %
54.79%
Holding
92
New
13
Increased
8
Reduced
23
Closed
11

Top Buys

1
PCVX icon
Vaxcyte
PCVX
$12M
2
BHVN icon
Biohaven
BHVN
$11.6M
3
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
$6.35M
4
BTAI icon
BioXcel Therapeutics
BTAI
$5.37M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$4.9M

Top Sells

1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$12.9M
2
ARDX icon
Ardelyx
ARDX
$5.13M
3
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$5.03M
4
SAGE
Sage Therapeutics
SAGE
$3.43M
5
ALT icon
Altimmune
ALT
$3.27M

Sector Composition

1 Healthcare 99.4%
2 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SGEN
26
DELISTED
Seagen Inc. Common Stock
SGEN
$3.21M 0.78%
+25,000
New +$3.21M
RCUS icon
27
Arcus Biosciences
RCUS
$1.24B
$2.85M 0.69%
+137,987
New +$2.85M
SAGE
28
DELISTED
Sage Therapeutics
SAGE
$2.59M 0.62%
67,805
-90,000
-57% -$3.43M
MRUS icon
29
Merus
MRUS
$5.04B
$2.41M 0.58%
+156,000
New +$2.41M
VKTX icon
30
Viking Therapeutics
VKTX
$3.02B
$1.91M 0.46%
203,156
-260,000
-56% -$2.44M
MIST icon
31
Milestone Pharmaceuticals
MIST
$151M
$1.82M 0.44%
460,416
-395,200
-46% -$1.56M
PRQR icon
32
ProQR Therapeutics
PRQR
$256M
$1.56M 0.38%
+422,625
New +$1.56M
ABOS icon
33
Acumen Pharmaceuticals
ABOS
$82.4M
$1.38M 0.33%
254,945
-95,055
-27% -$513K
ARKG icon
34
ARK Genomic Revolution ETF
ARKG
$1.05B
$1.31M 0.32%
46,462
-50,000
-52% -$1.41M
LYRA icon
35
Lyra Therapeutics
LYRA
$11.8M
$1.08M 0.26%
6,874
– –
ICPT
36
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.05M 0.25%
85,200
– –
PNT
37
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$1.02M 0.25%
139,565
-310,841
-69% -$2.27M
CMMB
38
Chemomab Therapeutics
CMMB
$15.7M
$1M 0.24%
78,348
+16,874
+27% +$216K
IMUX icon
39
Immunic
IMUX
$79.4M
$910K 0.22%
+650,000
New +$910K
COGT icon
40
Cogent Biosciences
COGT
$1.83B
$726K 0.18%
62,766
-100,000
-61% -$1.16M
OCUL icon
41
Ocular Therapeutix
OCUL
$2.25B
$562K 0.14%
200,000
-65,000
-25% -$183K
ELDN icon
42
Eledon Pharmaceuticals
ELDN
$155M
$515K 0.12%
221,830
– –
TARA icon
43
Protara Therapeutics
TARA
$125M
$506K 0.12%
188,664
– –
AUTL
44
Autolus Therapeutics
AUTL
$383M
$494K 0.12%
260,087
– –
IMTX icon
45
Immatics
IMTX
$662M
$427K 0.1%
49,031
– –
ANEB icon
46
Anebulo Pharmaceuticals
ANEB
$101M
$375K 0.09%
156,203
– –
OKUR
47
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$38.3M
$363K 0.09%
15,582
– –
PRAX icon
48
Praxis Precision Medicines
PRAX
$980M
$357K 0.09%
+10,000
New +$357K
XFOR icon
49
X4 Pharmaceuticals
XFOR
$70M
$347K 0.08%
11,638
-7,316
-39% -$218K
BLCM
50
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$323K 0.08%
448,101
– –
1
2
3 4